Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Y-90 Radioembolization Topic Center

Y-90 Radioembolization

Daniel B. Brown, MD, FSIR
Videos
Y90 Radioembolization for Patients With Hepatocellular Carcinoma Who Have Undergone Prior Resection
04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR,...
04/12/2024
IO Learning
Qian (Clark) Yu, MD, University of Chicago
Conference Coverage
Combining Transarterial Radioembolization and Systemic Therapy for Unresectable Cholangiocarcinoma
04/12/2024

Featuring Qian (Clark) Yu, MD

Featuring Qian (Clark) Yu, MD
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting, Clark Yu, MD, shared data on the combination of transarterial radioembolization with systemic capecitabine for patients with unresectable cholangiocarcinoma.
At the SIR 2024 Annual Meeting,...
04/12/2024
IO Learning
Andrew Kennedy, MD, Sarah Cannon Research Institute
Conference Coverage
Radioembolization With Imageable Glass Y90 Microspheres for Hepatocellular Carcinoma
04/03/2024

Featuring Andrew Kennedy, MD

Featuring Andrew Kennedy, MD
At the 2024 SIR Annual Meeting, Andrew Kennedy, MD, discusses the utilization of imageable glass Y90 microspheres in radioembolization for patients with hepatocellular carcinoma.
At the 2024 SIR Annual Meeting, Andrew Kennedy, MD, discusses the utilization of imageable glass Y90 microspheres in radioembolization for patients with hepatocellular carcinoma.
At the 2024 SIR Annual Meeting,...
04/03/2024
IO Learning
Ganguli CIO
Y90 Update on Metastatic Disease: 2022 Year in Review
Suvranu Ganguli, MD, FSIR presents notable 2022 studies on Y-90 for metastatic disease at the Symposium on Clinical Interventional Oncology.
01/06/2023
Tabori CIO
Y90: 2022 Year in Review
Nora Tabori, MD presents notable Y-90 studies at the Symposium on Clinical Interventional Oncology in 2022.
01/06/2023
Violari and Gandhi
Podcast
The Latest Advancements in Y-90 Radioembolization and Practical Tips for Building a Y-90 Program
12/13/2022
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the...
12/13/2022
IO Learning
CIO 2022-3 Updated Clinical and Dosimetric Recommendations for Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma
Purpose: The TheraSphere Global Dosimetry Steering Committee (DSC) reconvened to update the clinical and dosimetric recommendations for the treatment of unresectable hepatocellular carcin...
10/18/2022
CIO 2022-23 Radioembolization as a Locoregional Treatment of Hepatic Metastasis of Melanoma
Purpose: To evaluate the effectiveness, safety, and predictors of outcome of patients treated with yttrium-90 (90Y) radioembolization for hepatic involvement of metastatic melanoma. ...
10/18/2022
CIO 2022-30 Yttrium-90 Radioembolization Treatment of Patients With Liver-Dominant Metastatic Melanoma
Late-breaking abstract / This study aims to evaluate the safety and efficacy of Yttrium-90 radioembolization of patients with liver-dominant metastatic melanoma.
10/17/2022
Video
Liver Embolization in Pediatric Primary Hepatic Malignancies
10/12/2022
Dr Allison Aguado discusses current treatment options for pediatric primary hepatic malignancies, as well as her currently enrolling trial on clinical outcomes and quality of life after radioembolization in children with liver cancer.
Dr Allison Aguado discusses current treatment options for pediatric primary hepatic malignancies, as well as her currently enrolling trial on clinical outcomes and quality of life after radioembolization in children with liver cancer.
Dr Allison Aguado discusses...
10/12/2022
IO Learning
Dr Ripal Gandhi
SIR 2022
Dr Ripal Gandhi at SIR 2022
06/15/2022
"The difference between a patient with stable disease and a patient with a complete response really comes down to dosimetry." - Ripal Gandhi, MD, FSIR, FSVM, offers highlights from his Y-90 presentations at SIR 2022.
"The difference between a patient with stable disease and a patient with a complete response really comes down to dosimetry." - Ripal Gandhi, MD, FSIR, FSVM, offers highlights from his Y-90 presentations at SIR 2022.
"The difference between a...
06/15/2022
IO Learning

Video Presentations

Daniel B. Brown, MD, FSIR
Videos
Y90 Radioembolization for Patients With Hepatocellular Carcinoma Who Have Undergone Prior Resection
04/12/2024

Featuring Daniel B. Brown, MD, FSIR

Featuring Daniel B. Brown, MD, FSIR ...
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR, shares insights on an analysis of the RESiN study, evaluating the use of Y90 radioembolization for patients with hepatocellular carcinoma who had undergone previous resection.
Daniel B. Brown, MD, FSIR,...
04/12/2024
IO Learning
Ganguli CIO
Y90 Update on Metastatic Disease: 2022 Year in Review
Suvranu Ganguli, MD, FSIR presents notable 2022 studies on Y-90 for metastatic disease at the Symposium on Clinical Interventional Oncology.
01/06/2023
Tabori CIO
Y90: 2022 Year in Review
Nora Tabori, MD presents notable Y-90 studies at the Symposium on Clinical Interventional Oncology in 2022.
01/06/2023
Video
Liver Embolization in Pediatric Primary Hepatic Malignancies
10/12/2022
Dr Allison Aguado discusses current treatment options for pediatric primary hepatic malignancies, as well as her currently enrolling trial on clinical outcomes and quality of life after radioembolization in children with liver cancer.
Dr Allison Aguado discusses current treatment options for pediatric primary hepatic malignancies, as well as her currently enrolling trial on clinical outcomes and quality of life after radioembolization in children with liver cancer.
Dr Allison Aguado discusses...
10/12/2022
IO Learning
Dr Ripal Gandhi
SIR 2022
Dr Ripal Gandhi at SIR 2022
06/15/2022
"The difference between a patient with stable disease and a patient with a complete response really comes down to dosimetry." - Ripal Gandhi, MD, FSIR, FSVM, offers highlights from his Y-90 presentations at SIR 2022.
"The difference between a patient with stable disease and a patient with a complete response really comes down to dosimetry." - Ripal Gandhi, MD, FSIR, FSVM, offers highlights from his Y-90 presentations at SIR 2022.
"The difference between a...
06/15/2022
IO Learning
Leveraging the SIR-Spheres Advantage to Build a Successful Y-90 Program in a Community Setting
Sabina Amin, MD discusses the current research findings on SIR-Spheres microspheres.
02/17/2022
Dose Matters
Nora Tabori, MD, Edward Kim, MD, and Riad Salem, MD present current thoughts on Y-90 dosimetry based on the EPOCH trial.
02/16/2022
Combo Therapy
Combination Therapies: Your Questions Answered
02/05/2022
Y-90 Radioembolization in the OBL Setting
02/05/2022
Y-90 Dose Matters: But How Do You Choose?
02/05/2022
AJ Gunn, MD, University of Alabama at Birmingham
Videos
Percutaneous Renal Ablation
10/17/2024
AJ Gunn, MD, discusses percutaneous renal ablation.
AJ Gunn, MD, discusses percutaneous renal ablation.
AJ Gunn, MD, discusses...
10/17/2024
IO Learning
Altan Ahmed, MD, Moffitt Cancer Center
Videos
Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
10/16/2024
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses...
10/16/2024
IO Learning
Nainesh Parikh, MD, Moffitt Cancer Center
Videos
Emerging Indications for Prostate Artery Embolization
10/16/2024
Nainesh Parikh, MD, discusses the emerging indications for prostate artery embolization among patients with prostate cancer.
Nainesh Parikh, MD, discusses the emerging indications for prostate artery embolization among patients with prostate cancer.
Nainesh Parikh, MD, discusses...
10/16/2024
IO Learning
Nadine Abi-Jaoudeh, MD, University of California, Irvine
Videos
Oncology Drugs With an Impact on IR Procedures
10/16/2024
Nadine Abi-Jaoudeh, MD, discusses the drugs that interventional radiologists should be on the lookout for when treating patients with cancer.
Nadine Abi-Jaoudeh, MD, discusses the drugs that interventional radiologists should be on the lookout for when treating patients with cancer.
Nadine Abi-Jaoudeh, MD,...
10/16/2024
IO Learning
Ripal Gandhi, MD, FSVM
Videos
Interventional Approaches for Locally Advanced Pancreatic Cancer
10/15/2024
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM,...
10/15/2024
IO Learning
Osman Ahmed, MD, University of Chicago Medicine
Videos
Intratumor Injections in Interventional Oncology
10/15/2024
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the...
10/15/2024
IO Learning
Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center
Videos
Cryoablation For Breast Cancer: Efficacy and Techniques
10/03/2024
At the 2024 CIO Meeting, Yolanda Bryce, MD, discusses the use of cryoablation for patients with breast cancer.
At the 2024 CIO Meeting, Yolanda Bryce, MD, discusses the use of cryoablation for patients with breast cancer.
At the 2024 CIO Meeting, Yolanda...
10/03/2024
IO Learning
Edward Kim, MD
Videos
Previewing the 2024 Symposium on Clinical Interventional Oncology Agenda
08/28/2024
Edward Kim, MD, shares what he is most excited about at this year’s upcoming Symposium on Clinical Interventional Oncology.
Edward Kim, MD, shares what he is most excited about at this year’s upcoming Symposium on Clinical Interventional Oncology.
Edward Kim, MD, shares what he...
08/28/2024
IO Learning
Nadine Abi-Jaoudeh, MD, University of California, Irvine
Videos
What to Look Forward to at This Year’s Symposium on Clinical Interventional Oncology
08/28/2024
Nadine Abi-Jaoudeh, MD, shares what she is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, shares what she is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, shares...
08/28/2024
IO Learning

CIO Abstracts

CIO 2022-3 Updated Clinical and Dosimetric Recommendations for Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma
Purpose: The TheraSphere Global Dosimetry Steering Committee (DSC) reconvened to update the clinical and dosimetric recommendations for the treatment of unresectable hepatocellular carcin...
10/18/2022
CIO 2022-23 Radioembolization as a Locoregional Treatment of Hepatic Metastasis of Melanoma
Purpose: To evaluate the effectiveness, safety, and predictors of outcome of patients treated with yttrium-90 (90Y) radioembolization for hepatic involvement of metastatic melanoma. ...
10/18/2022
CIO 2022-30 Yttrium-90 Radioembolization Treatment of Patients With Liver-Dominant Metastatic Melanoma
Late-breaking abstract / This study aims to evaluate the safety and efficacy of Yttrium-90 radioembolization of patients with liver-dominant metastatic melanoma.
10/17/2022
CIO 2021-5 Y-90 Radioembolization for Neuroendocrine Tumor Liver Metastases and Periprocedural Hemodynamic Instability
Purpose: Transarterial radioembolization (TARE) is commonly used for treatment of neuroendocrine tumor liver metastases (NETLMs). Hormonal release causing hemodynamic instability and carc...
11/15/2021
CIO 2021-6 Radiation Segmentectomy for Oligometastatic Disease to the Liver: A Single Institution Experience
Purpose: To evaluate patient safety and treatment outcomes of radiation segmentectomy for metastatic disease to the liver.
11/15/2021
CIO 2021-13 Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma
Purpose: The aim of this study is to examine the clinical outcomes of yttrium-90 (Y90) transarterial radioembolization (TARE) of primary hepatocellular carcinoma (HCC) through evaluation ...
11/15/2021
CIO 2021-15 Long-Term Outcomes Following Y90 Radioembolization of Neuroendocrine Liver Metastases
Purpose: 90Y radioembolization has been studied as an effective therapy for neuroendocrine liver metastases (NELM). We aim to further characterize treatment outcomes as it relates to the ...
11/15/2021
CIO 2021-17 Calculated Activity Comparison Based on Contouring Technique for Resin Y-90 Microsphere Liver Radioembolization
Purpose: Delineation of liver, hepatic lobes, and gross tumor volumes (GTV) is necessary for activity calculation of resin Y-90 microsphere radioembolization. Hepatic lobe delineation can...
11/15/2021
CIO 2021-18 Evaluating Effect of Vascularity on Micro-Embolic Performance of Y-90 Microspheres Using Novel Hepatic Tumor Model
Purpose: The purpose of this study was to investigate the impact of vascularity on radioembolic performance in a simulated liver tumor using 20-30μm diameter glass Y-89 microspheres (MS)....
11/15/2021
CIO 2021-21 Y-90 Radioembolization of Unresectable High-Risk Hepatic Adenoma in a Patient With Chronic Liver Disease
Purpose: To describe the use of Y-90 radioembolization (Y-90 RE) for unresectable high risk hepatic adenoma in a patient with chronic liver disease.
11/15/2021
Ebstesam Nafie
CIO2023 Highlights
A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields
12/14/2023
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her...
12/14/2023
IO Learning
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
CIO2023 Highlights
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck
CIO2023 Highlights
Thyroid Ablation After Thyroid Cancer Recurrence in a Hostile Neck
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
CIO2023 Highlights
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her...
11/30/2023
IO Learning
Brendan Ryu
CIO2023 Highlights
Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review
11/14/2023
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his...
11/14/2023
IO Learning
Ashwin Mahendra
CIO2023 Highlights
Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia
11/13/2023
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his...
11/13/2023
IO Learning
CIO 2023-34 Radioembolization Plus Gemcitabine, Cisplatin, and Capecitabine as First-Line Therapy for Intrahepatic Cholangiocarcinoma
Purpose: To report outcomes of an institutional downstaging protocol for intrahepatic cholangiocarcinoma (iCCA) using radioembolization (TARE), gemcitabine, cisplatin, and capecitabine co...
11/02/2023
CIO 2023-33 Tumor Size and Watershed Area Correlates in Progression of Hepatocellular Carcinoma after Segmental Radioembolization
Purpose: To identify factors of incomplete treatment after segmental transarterial radioembolization (TARE) for treatment-naïve and solitary hepatocellular carcinoma (HCC)
11/02/2023
CIO 2023-32 Transradial versus Transfemoral Access for Interventional Oncology Procedures: A Systematic Review and Meta-Analysis
Purpose: The procedural and clinical outcomes of a transradial approach (TRA) versus a transfemoral approach (TFA) for interventional oncology (IO) procedures remain unclear.
11/02/2023
CIO 2023-26 The Cost of Catheter Dislodgement
Purpose: Long term care of patient's with complicated disease processes often incurs significant financial burden. This burden if often complicated with misuse or failure of medical devic...
11/02/2023

Podcasts and Interviews

Violari and Gandhi
Podcast
The Latest Advancements in Y-90 Radioembolization and Practical Tips for Building a Y-90 Program
12/13/2022
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the...
12/13/2022
IO Learning
TARGET
Podcast and Video
TARGET Study Confirms the Significance of Tumor Absorbed Dose of Tumor Response and Overall Survival
06/05/2021
TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....
TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....
TARGET is a global real-world...
06/05/2021
IO Learning
LEGACY
Podcasts
The LEGACY Study Confirms TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
12/10/2020
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma.
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma.
In this episode of IOL Radio, we...
12/10/2020
IO Learning
Interview
PRRT and Y-90: Patient Selection, Treatment Decisions, and Upcoming Research
07/15/2019
Peptide receptor radionuclide therapy (PRRT) is a potential therapy option for patients with metastatic neuroendocrine tumor, but questions remain about patient selection and treatment decisions in conjunction with arterial therapy,...
Peptide receptor radionuclide therapy (PRRT) is a potential therapy option for patients with metastatic neuroendocrine tumor, but questions remain about patient selection and treatment decisions in conjunction with arterial therapy,...
Peptide receptor radionuclide...
07/15/2019
IO Learning
Dr Edward Kim
Sponsored Interview
Upgrading Interventional Labs to Improve Workflow and Efficiency at Mount Sinai Health System
10/17/2024
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai...
10/17/2024
Vascular Disease Management
IO Learning logo
Podcasts
The Importance of the Society of Interventional Oncology Annual Meeting
10/10/2024
In this episode of the SIO Corner podcast, Muneeb Ahmed, MD, and Michael Soulen, MD, join AJ Gunn, MD, to talk about the origin of the Society of Interventional Oncology, where it fits in along the other radiology societies, and how the SIO...
In this episode of the SIO Corner podcast, Muneeb Ahmed, MD, and Michael Soulen, MD, join AJ Gunn, MD, to talk about the origin of the Society of Interventional Oncology, where it fits in along the other radiology societies, and how the SIO...
In this episode of the SIO...
10/10/2024
IO Learning
Govindarajan Narayanana, MD, Miami Cardiac and Vascular Disease Institute
Podcasts
Irreversible Electroporation for Pancreatic Cancer
09/26/2024
Elena Violari, MD, RPVI, discusses irreversible electroporation for pancreatic cancer with Govindarajan Narayanan, MD, in the latest episode of the SIO Corner podcast.
Elena Violari, MD, RPVI, discusses irreversible electroporation for pancreatic cancer with Govindarajan Narayanan, MD, in the latest episode of the SIO Corner podcast.
Elena Violari, MD, RPVI,...
09/26/2024
IO Learning
Premal Trivedi, MD; Junaid Raja, MD, MSPH; John Smirniotopoulos, MD
Podcasts
Cholangioscopy: What Interventional Oncologists Need to Know
08/21/2024
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner...
08/21/2024
IO Learning
Premal Trivedi, MD; Junaid Raja, MD, MSPH; John Smirniotopoulos, MD
Podcasts
Cholangioscopy: What Interventional Oncologists Need to Know
08/21/2024
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner podcast, Junaid Raja, MD, MSPH, John Smirniotopoulos, MD, and Premal Trivedi, MD, join our host, Elena Violari, MD, RPVI to discuss the ins and outs of cholangioscopy.
In the latest SIO Corner...
08/21/2024
IO Learning
Katerina Lee, MD
Podcasts
Augmented Reality for Multi-Needle Composite Liver Tumor Ablation
06/20/2024
Katerina Lee, MD
Andrew Kolarich, MD
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
In this episode of the SIO...
06/20/2024
IO Learning
Dania Daye, MD, PhD, Massachusetts General Hospital
Podcasts
How Artificial Intelligence May Change Interventional Oncology
04/23/2024

Featuring Dania Daye, MD, PhD

Featuring Dania Daye, MD, PhD
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this episode of the SIO Corner podcast to share insights on how AI can be used to improve clinical practice in interventional oncology and other medical fields.
Dania Daye, MD, PhD, joins this...
04/23/2024
IO Learning
Q&As
Compliance With Interventional Oncology Accreditation Standards Among Interventional Radiologists
03/25/2024

Featuring Murat Dökdök, MD

Featuring Murat Dökdök, MD
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the...
03/25/2024
IO Learning
Constantino Peña, MD, Miami Cancer Institute
Videos
The Importance of a Multidisciplinary Approach in Interventional Oncology
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Jack Jennings, MD, PhD, Washington University in St Louis
Videos
Treatment of Primary and Metastatic Sarcoma
02/06/2024
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting,...
02/06/2024
IO Learning

Subscribe

IO Learning Newsletter

News

News
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
02/10/2022
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres Y-90 resin microspheres have been approved by the National Medical Products...
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres Y-90 resin microspheres have been approved by the National Medical Products...
Sirtex Medical, a leading...
02/10/2022
IO Learning
News
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
09/20/2021
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
Late-Breaking Data Demonstrate...
09/20/2021
IO Learning
News
Late-Breaking Clinical Trial Data for TheraSphere™ Y-90 Glass Microspheres Demonstrates Improved Survival in Primary Liver Cancer
03/25/2021
Data presented at SIR 2021 confirm safety and dose-efficacy relationship MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced positive data from the TARGET study of the...
Data presented at SIR 2021 confirm safety and dose-efficacy relationship MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced positive data from the TARGET study of the...
Data presented at SIR 2021...
03/25/2021
IO Learning
News
ASCO Peer Review Supports the Benefits of SIR-Spheres Y-90 Resin Microspheres in the Liver
06/01/2015
SIRFLOX results confirmed as both statistically significant and clinically meaningful in the liverAnticipate first-line utilisation in metastatic colorectal cancerSIRFLOX study selected by ASCO as one of the “Best of ASCO”...
SIRFLOX results confirmed as both statistically significant and clinically meaningful in the liverAnticipate first-line utilisation in metastatic colorectal cancerSIRFLOX study selected by ASCO as one of the “Best of ASCO”...
SIRFLOX results confirmed as...
06/01/2015
IO Learning
News
Y-90 Provides New, Safe Treatment for Metastatic Breast Cancer
03/24/2014
Largest Study of Its Kind Shows Minimally Invasive Treatment May Slow Disease Progression in Liver While Maintaining Quality of Life SAN DIEGO (March 24, 2014)—A minimally invasive treatment that delivers cancer-killing radiation...
Largest Study of Its Kind Shows Minimally Invasive Treatment May Slow Disease Progression in Liver While Maintaining Quality of Life SAN DIEGO (March 24, 2014)—A minimally invasive treatment that delivers cancer-killing radiation...
Largest Study of Its Kind Shows...
03/24/2014
IO Learning
News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement